President and Chief Executive Officer · Editas Medicine, Inc. (EDIT)

Gilmore M.Sc

FY2022 is the first fiscal year CompBrief holds for Gilmore M.Sc as a named executive officer of Editas Medicine; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$9,058,900

Salary $355,769Stock awards $999,999

1st of 4 named executive officers at Editas Medicine by FY2022 total.

4 named officers on file for Editas Medicine, FY2022

Gilmore M.Sc’s pay file — $29

  • 1 fiscal year of pay, line by line
  • EDIT’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Editas Medicine’s whole pay program stands against its peers

  • Editas Medicine’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on EDIT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2023 (DEF 14A).

Free

Get Gilmore M.Sc’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Gilmore M.Sc compensation by year

Editas Medicine Summary Compensation Table · the one fiscal year held
In US dollars, as Editas Medicine reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$355,769
Bonus$0
Stock awards$999,999
Option awards$7,495,059
Non-equity incentive$201,329
Pension and deferred compensation$0
All other$6,744
Total$9,058,900

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Editas Medicine, Inc. DEF 14A filed April 18, 2023, accession 0001104659-23-046732, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Editas Medicine, Inc. filed document, accession 0001104659-23-046732. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2023.

Editas Medicine’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Gilmore M.Sc · this pagePresident and Chief Executive Officer$9,058,900
Michelle RobertsonFormer Executive Vice President and Chief Financial Officer$3,422,086
Baisong MeiSenior Vice President and Chief Medical Officer$3,010,747
Bruce EatonFormer Executive Vice President and Chief Business Officer$2,735,748

The full Editas Medicine compensation record

free company brief

This page is one person within Editas Medicine's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Editas Medicine proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Editas Medicine's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Gilmore M.Sc's compensation dossier · One-time report. No refunds.